GSK Cough Study. A prospective Cohort Study of Patients with Refractory or Unexplained Chronic Cough measuring Cough Variability and Burden on Patients' Lives.
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
GlaxoSmithKline
Start Date
February 5, 2026
End Date
July 4, 2030
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
GlaxoSmithKline
Start Date
February 5, 2026
End Date
July 4, 2030